HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

L’Oreal Appeals NAD Ruling On Eyelash Enhancement

This article was originally published in The Rose Sheet

Executive Summary

A National Advertising Division decision concerning implied and express claims in L’Oreal USA ads for mascara products reinforces the watchdog’s position on artificial enhancements to cosmetic advertising that exaggerate potential product benefits – this time focusing on physical (versus digital) alterations.

You may also be interested in...



ASA Ruling Signals UK May Be Less Tolerant Of Lash Inserts In Mascara Ads

Use of lash inserts in mascara ads has been a subject of contention in the US, but a 2014 verdict from the National Advertising Review Board essentially green-lighted their continued use with proper disclaimers. The same leeway may not be available in the UK, based on an April 19 ruling from the Advertising Standards Authority.

Are Beauty Ads Held To Unique Standards? NARB Ruling Spurs Debate

At the National Advertising Division’s Annual Conference, NAD staffers, FTC officials and attorneys discussed whether beauty ads are regulated differently from advertising in other industries. L’Oreal’s successful appeal of a recent NAD decision regarding the use of lash inserts in Maybelline mascara ads could set a new and questionable precedent, according to NAD Director Andrea Levine.

Bill Directs FTC To Take Action On Photoshopped Ads

A new bill presented in the House instructs the FTC to examine the use of ads that alter the physical characteristics of the face and body and develop a strategy to address the issue and reduce their use.

Related Content

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018733

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel